New Delhi, Apr 3 (UNI) In a bid to spread its network, Dabur OncQuest, a subsidiary of Dabur Pharma, today said it has forayed into Nepal through the tie-up with local firm Annapurna Diagnostic to provide testing facilities for cancer patients.
''Kathmandu being the business hub of Nepal was zeroed down as the best location for collection centre. Through this, the patients in Nepal will now have access to all the technically advanced and cost-effective diagnostic tests being offered by Dabur OncQuest in India,'' company Head Diagnostics Vivek Trikha said here.
The company did a pilot run and diagnosed samples of over 200 patients leading to business of more than 15 lakhs, he said.
''With the successful and much appreciated completion of the project, we have won the confidence of doctors and patients. We are pleased to announce our full-fledged services in Nepal through our first commercial collection center in Kathmandu,'' Mr Trikha said.
The company plans to further develop two more collection centres at Bharatpur and Chitwann in Nepal.
Dabur OncQuest, started its operations in 2003, has expertise to evaluate the structure of DNA, RNA and proteins in cells.
UNI MP SBA KP2028